ClinicalTrials.gov
public full text
Public Domain
Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
This phase I trial is studying the side effects and best dose of decitabine in treating patients with myelodysplastic syndromes or acute myeloid leukemia. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Low-Dose Decitabine in Treating Patients With Symptomatic Myelofibrosis#877605
- Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse#1371064
- Decitabine in Treating Patients With Myelofibrosis#1281134
- Decitabine in Treating Patients With Previously Untreated Acute Myeloid Leukemia#884716
- Decitabine in Treating Patients With Advanced Solid Tumors#1246143
Record · ID 1369535
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive